These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39239010)

  • 41. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report.
    Veisi A; Bagheri A; Eshaghi M; Rikhtehgar MH; Rezaei Kanavi M; Farjad R
    Eur J Ophthalmol; 2022 Jul; 32(4):NP11-NP16. PubMed ID: 33843287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Case of Bilateral Central Retinal Artery Occlusion in a Post-COVID Rhino-Orbital-Cerebral Mucormycosis Patient.
    Patnaik A; Sharma B; Ahmad R; Kumar A; Chitrotpala R; Gupta M
    Cureus; 2021 Nov; 13(11):e20062. PubMed ID: 35003938
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival from Rhino-Orbital-Cerebral Mucormycosis in SARS-CoV-2-Positive Diabetic Patients: Two Case Reports.
    Lädrach C; Wartenberg M; Zimmerli S; Anschuetz L; Bohlen S; Ebner J; de Gouyon Matignon de Pontouraude CMF; Caversaccio M; Wagner F
    Case Rep Neurol; 2024; 16(1):89-98. PubMed ID: 38690082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.
    Farooq S; Khan NA; Singh A; Khan A; Sharma P; Meena R; Jakhar A; Kumar M; Kochar A
    Cureus; 2023 Jun; 15(6):e41010. PubMed ID: 37519583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
    Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
    Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
    Nair AG; Dave TV
    Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.
    B H S; Bidkar V; Prathipati K; Dabhekar S; Selvaraj K; G D
    Cureus; 2024 Apr; 16(4):e59007. PubMed ID: 38800245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Profile of Central Nervous System Involvement in Patients with Rhino Orbital Cerebral Mucormycosis.
    Yadav S; Bs N; Ak S
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-COVID-19 rhino-orbito-cerebral mucormycosis-A clinico-mycological study from North India.
    Taneja J; Chatterjee K; Sasidharan J; Abbas SZ; Rai AK; Raychaudhury S; Das B; Das A
    Med Mycol; 2023 Jul; 61(7):. PubMed ID: 37442616
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rhino-orbito-cerebral mucormycosis during Covid-19 pandemic- a prospective observational study.
    Fatima N; Ahmed S; Shameem M; Ahmed A; Hasan W; Khan PA
    Indian J Med Microbiol; 2023; 46():100467. PubMed ID: 37651764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rhinocerebral mucormycosis in a diabetes type 2 patient: A fatal case report from northern Tanzania.
    Chussi DC; Kayuza M; Magwizi M; Shija P; Sadiq A; Amsi P; Katundu D; Mtenga P
    SAGE Open Med Case Rep; 2022; 10():2050313X221078721. PubMed ID: 35223035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients.
    Kim U; Perzia B; Kulkarni P; Rajiniganth M; Sundar B; Robin AL; Garg Shukla A; Maeng MM
    Orbit; 2024 Jul; ():1-10. PubMed ID: 39051497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rhino-orbital-cerebral mucormycosis as a complication of coronavirus disease 2019.
    Al-Ani RM
    World J Virol; 2022 Sep; 11(5):293-299. PubMed ID: 36188746
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
    Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
    Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronical rhino-orbital mucormycosis in an immunocompetent host: A case report.
    Razem B; Dennai Y; Slimani F
    Int J Surg Case Rep; 2021 May; 82():105882. PubMed ID: 33865198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic rhino-orbito-cerebral mucormycosis: A case report and review of the literature.
    Gutiérrez-Delgado EM; Treviño-González JL; Montemayor-Alatorre A; Ceceñas-Falcón LA; Ruiz-Holguín E; Andrade-Vázquez CJ; Lara-Medrano R; Ramos-Jiménez J
    Ann Med Surg (Lond); 2016 Mar; 6():87-91. PubMed ID: 26981237
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
    Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
    Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.